Table of Contents
Thrombosis
Volume 2012, Article ID 367823, 6 pages
http://dx.doi.org/10.1155/2012/367823
Research Article

Lack of Association between Recurrent Pregnancy Loss and Inherited Thrombophilia in a Group of Colombian Patients

1Grupo Reproducción, Universidad de Antioquia, Medellín, Colombia
2Grupo de Estudio en Trombosis, Universidad de Antioquia, Medellín, Colombia
3Departamento de Ginecología y Obstetricia, Universidad de Antioquia and Hospital Universitario San Vicente de Paúl, Medellín, Colombia
4GENMOL, Universidad de Antioquia, Medellín, Colombia

Received 9 November 2011; Accepted 27 January 2012

Academic Editor: Solaf Elsayed

Copyright © 2012 Henry Cardona et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Gemmati, M. L. Serino, S. Moratelli, S. Tognazzo, A. Ongaro, and G. L. Scapoli, “Coexistence of factor V G1691A and factor II G20210A gene mutations in a thrombotic family is associated with recurrence and early onset of venous thrombosis,” Haemostasis, vol. 31, no. 2, pp. 99–105, 2001. View at Google Scholar · View at Scopus
  2. R. Rai and L. Regan, “Thrombophilia and adverse pregnancy outcome,” Seminars in Reproductive Medicine, vol. 18, no. 4, pp. 369–378, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Stirling, L. Woolf, and W. R. S. North, “Haemostasis in normal pregnancy,” Thrombosis and Haemostasis, vol. 52, no. 2, pp. 176–182, 1984. View at Google Scholar
  4. S. Jivraj, B. Anstie, Y. C. Cheong, F. M. Fairlie, S. M. Laird, and T. C. Li, “Obstetric and neonatal outcome in women with a history of recurrent miscarriage: a cohort study,” Human Reproduction, vol. 16, no. 1, pp. 102–106, 2001. View at Google Scholar · View at Scopus
  5. O. B. Christiansen, A. M. N. Andersen, E. Bosch et al., “Evidence-based investigations and treatments of recurrent pregnancy loss,” Fertility and Sterility, vol. 83, no. 4, pp. 821–839, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Sarig, J. S. Younis, R. Hoffman, N. Lanir, Z. Blumenfeld, and B. Brenner, “Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage,” Fertility and Sterility, vol. 77, no. 2, pp. 342–347, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. M. L. Wramsby, M. Sten-Linder, and K. Bremme, “Primary habitual abortions are associated with high frequency of Factor V Leiden mutation,” Fertility and Sterility, vol. 74, no. 5, pp. 987–991, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Brenner, G. Sarig, Z. Weiner, J. Younis, Z. Blumenfeld, and N. Lanir, “Thrombophilic polymorphisms are common in women with fetal loss without apparent cause,” Thrombosis and Haemostasis, vol. 82, no. 1, pp. 6–9, 1999. View at Google Scholar · View at Scopus
  9. S. S. Souza, R. A. Ferriani, A. G. Pontes, M. A. Zago, and R. F. Franco, “Factor V Leiden and factor II G20210A mutations in patients with recurrent abortion,” Human Reproduction, vol. 14, no. 10, pp. 2448–2450, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. C. S. Goodman, C. B. Coulam, R. S. Jeyendran, V. A. Acosta, and R. Roussev, “Which thrombophilic gene mutations are risk factors for recurrent pregnancy loss?” American Journal of Reproductive Immunology, vol. 56, no. 4, pp. 230–236, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. Z. J. Foka, A. F. Lambropoulos, H. Saravelos et al., “Factor V Leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages,” Human Reproduction, vol. 15, no. 2, pp. 458–462, 2000. View at Google Scholar · View at Scopus
  12. G. Kovalevsky, C. R. Gracia, J. A. Berlin, M. D. Sammel, and K. T. Barnhart, “Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss: a meta-analysis,” Archives of Internal Medicine, vol. 164, no. 5, pp. 558–563, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Pihusch, T. Buchholz, P. Lohse et al., “Thrombophilic gene mutations and recurrent spontaneous abortion: prothrombin mutation increases the risk in the first trimester,” American Journal of Reproductive Immunology, vol. 46, no. 2, pp. 124–131, 2001. View at Google Scholar
  14. E. Rey, S. R. Kahn, M. David, and I. Shrier, “Thrombophilic disorders and fetal loss: a meta-analysis,” Lancet, vol. 361, no. 9361, pp. 901–908, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Rai, A. Shlebak, H. Cohen et al., “Factor V leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage,” Human Reproduction, vol. 16, no. 5, pp. 961–965, 2001. View at Google Scholar · View at Scopus
  16. H.-U. Pauer, T. Voigt-Tschirschwitz, B. Hinney et al., “Analyzes of three common thrombophilic gene mutations in German women with recurrent abortions,” Acta Obstetricia et Gynecologica Scandinavica, vol. 82, no. 10, pp. 942–947, 2003. View at Publisher · View at Google Scholar
  17. W. H. Kutteh, V. M. Park, and S. R. Deitcher, “Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss,” Fertility and Sterility, vol. 71, no. 6, pp. 1048–1053, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Pickering, K. Marriott, and L. Regan, “G20210A prothrombin gene mutation: prevalence in a recurrent miscarriage population,” Clinical and Applied Thrombosis/Hemostasis, vol. 7, no. 1, pp. 25–28, 2001. View at Google Scholar · View at Scopus
  19. H. Carp, O. Salomon, D. Seidman, R. Dardik, N. Rosenberg, and A. Inbal, “Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss,” Human Reproduction, vol. 17, no. 6, pp. 1633–1637, 2002. View at Google Scholar · View at Scopus
  20. P. W. Friederich, B. J. Sanson, P. Simioni et al., “Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis,” Annals of Internal Medicine, vol. 125, no. 12, pp. 955–960, 1996. View at Google Scholar · View at Scopus
  21. L. Regan and R. Rai, “Thrombophilia and pregnancy loss,” Journal of Reproductive Immunology, vol. 55, no. 1-2, pp. 163–180, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. M. J. Kupferminc, “Thrombophilia and pregnancy,” Current Pharmaceutical Design, vol. 11, no. 6, pp. 735–748, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Bedoya, P. Montoya, J. García et al., “Admixture dynamics in Hispanics: a shift in the nuclear genetic ancestry of a South American population isolate,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 19, pp. 7234–7239, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. L. G. Carvajal-Carmona, I. D. Soto, N. Pineda et al., “Strong Amerind/white sex bias and a possible Sephardic contribution among the founders of a population in Northwest Colombia,” American Journal of Human Genetics, vol. 67, no. 5, pp. 1287–1295, 2000. View at Google Scholar · View at Scopus
  25. F. H. Herrmann, M. Koesling, W. Schröder et al., “Prevalence of factor V Leiden mutation in various populations,” Genetic Epidemiology, vol. 14, no. 4, pp. 403–411, 1997. View at Publisher · View at Google Scholar
  26. M. J. Kupferminc, A. Eldor, N. Steinman et al., “Increased frequency of genetic thrombophilia in women with complications of pregnancy,” New England Journal of Medicine, vol. 340, no. 1, pp. 9–13, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. R. P. Murphy, C. Donoghue, R. J. Nallen et al., “Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 1, pp. 266–270, 2000. View at Google Scholar · View at Scopus
  28. A. Raziel, Y. Kornberg, S. Friedler, M. Schachter, B. A. Sela, and R. Ron-El, “Hypercoagulable thrombophilic defects and hyperhomocysteinemia in patients with recurrent pregnancy loss,” American Journal of Reproductive Immunology, vol. 45, no. 2, pp. 65–71, 2001. View at Google Scholar · View at Scopus
  29. P. M. Ridker, J. P. Miletich, C. H. Hennekens, and J. E. Buring, “Ethnic distribution of factor V Leiden in 4047 men and women: implications for venous thromboembolism screening,” Journal of the American Medical Association, vol. 277, no. 16, pp. 1305–1307, 1997. View at Google Scholar · View at Scopus
  30. S. R. Poort, F. R. Rosendaal, P. H. Reitsma, and R. M. Bertina, “A common genetic variation in the 3-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis,” Blood, vol. 88, no. 10, pp. 3698–3703, 1996. View at Google Scholar · View at Scopus
  31. H. Mandel, B. Brenner, M. Berant et al., “Coexistence of hereditary homocystinuria and Factor V Leiden—effect on thrombosis,” New England Journal of Medicine, vol. 334, no. 12, pp. 763–768, 1996. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Pérez, N. Rodríguez, J. Gil, and G. Ramírez, “Tamaño de muestra. In. (Bogotá, Pontificia Universidad Javeriana. Facultad de Medicina. Unidad de Epidemiología Clínica y Bioestadística.), p Programa sistematizado para el cálculo del tamaño de la muestra y el poder en diseños de investigación,” 2001.
  33. SPSS 15.0 Command Syntax Reference, SPSS Inc., Chicago, Ill, USA, for Windows, 2006.
  34. A. G. Dean, J. A. Dean, D. Coulombier et al., “EPI 6 STAT CALC,” in Epi Info Version 6: A Word Processing, Database, and Statistics Program for Epidemiology on Microcomputers, Atlanta, Ga, USA, 1994. View at Google Scholar
  35. O. Camacho Vanegas, B. Giusti, C. M. Restrepo Fernandez, R. Abbate, and G. Pepe, “Frequency of factor V (FV) Leiden and C677T methylenetetrahydrofolate reductase (MTHFR) mutations in Colombians,” Thrombosis and Haemostasis, vol. 79, no. 4, pp. 883–884, 1998. View at Google Scholar · View at Scopus
  36. A. Varela, A. Bilbao, C. F. Garcia et al., “Prevalencia de la mutacion del factor V de la coagulacion (factor V Leiden) en donantes de banco de sangre en cuatro ciudades colombianas,” Acta Médica Colombiana, vol. 25, pp. 2–5, 2000. View at Google Scholar
  37. J. D. Torres Hernández, H. Cardona, L. Álvarez et al., “Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population,” American Journal of Hematology, vol. 81, no. 12, pp. 933–937, 2006. View at Publisher · View at Google Scholar
  38. A. Roman-Gonzalez, H. Cardona, W. Cardona-Maya et al., “The first homozygous family for prothrombin G20210A polymorphism reported in Latin America,” Clinical and Applied Thrombosis/Hemostasis, vol. 15, no. 1, pp. 113–116, 2009. View at Publisher · View at Google Scholar
  39. I. Krabbendam, A. Franx, M. L. Bots, R. Fijnheer, and H. W. Bruinse, “Thrombophilias and recurrent pregnancy loss: a critical appraisal of the literature,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 118, no. 2, pp. 143–153, 2005. View at Publisher · View at Google Scholar
  40. E. Nurk, G. S. Tell, H. Refsum, P. M. Ueland, and S. E. Vollset, “Factor V Leiden, pregnancy complications and adverse outcomes. The Hordaland Homocysteine Study,” Quarterly Journal of Medicine, vol. 99, no. 5, pp. 289–298, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Balasch, J. C. Reverter, F. Fábregues et al., “First-trimester repeated abortion is not associated with activated protein C resistance,” Human Reproduction, vol. 12, no. 5, pp. 1094–1097, 1997. View at Google Scholar
  42. D. S. Dizon-Townson, S. Kinney, D. Ware Branch, and K. Ward, “The factor V Leiden mutation is not a common cause of recurrent miscarriage,” Journal of Reproductive Immunology, vol. 34, no. 3, pp. 217–223, 1997. View at Publisher · View at Google Scholar · View at Scopus
  43. Z. R. Holmes, L. Regan, I. Chilcott, and H. Cohen, “The C677T MTHFR gene mutation is not predictive of risk for recurrent fetal loss,” British Journal of Haematology, vol. 105, no. 1, pp. 98–101, 1999. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Makino, T. Nakanishi, M. Sugiura-Ogasawara, Y. Ozaki, N. Suzumori, and K. Suzumori, “No association of C677T methylenetetrahydrofolate reductase and an endothelial nitric oxide synthase polymorphism with recurrent pregnancy loss,” American Journal of Reproductive Immunology, vol. 52, no. 1, pp. 60–66, 2004. View at Google Scholar · View at Scopus
  45. H. U. Pauer, J. Neesen, and B. Hinney, “Factor V Leiden and its relevance in patients with recurrent abortions [8],” American Journal of Obstetrics and Gynecology, vol. 178, no. 3, p. 629, 1998. View at Google Scholar · View at Scopus
  46. T. Ayadurai, S. Muniandy, and S. Z. Omar, “Thrombophilia investigation in Malaysian women with recurrent pregnancy loss,” Journal of Obstetrics and Gynaecology Research, vol. 35, no. 6, pp. 1061–1068, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. A. M. Otero, R. Pou Ferrari, E. Pons et al., “Trombofilia y pérdida recurrente de embarazo,” Revista Médica del Uruguay, vol. 20, pp. 106–113, 2004. View at Google Scholar
  48. H. Yamada, E. H. Kato, G. Kobashi et al., “Recurrent pregnancy loss: etiology of thrombophilia,” Seminars in Thrombosis and Hemostasis, vol. 27, no. 2, pp. 121–130, 2001. View at Publisher · View at Google Scholar